American journal of hypertension

publication venue for

Mosaicism for KCNJ5 Causing Early-Onset Primary Aldosteronism due to Bilateral Adrenocortical Hyperplasia. 2020
Treatment of atheroembolization with corticosteroids. 2001
Persistent white coat hypertension. 1994
Hypertension and a tumor of the glomus jugulare region. Evidence for epinephrine biosynthesis. 1993
Sex differences in atrial fibrillation and associated complications in hypertensive patients with left ventricular hypertrophy: The LIFE study. 2023
Estimated population health benefits of intensive systolic blood pressure treatment among SPRINT-eligible US adults. 2023
Peer Counsellor Intervention for Reducing Mortality and/or Hospitalization in Adults with Hypertensive Urgency in Tanzania: A pilot study. 2023
Blood Pressure and Body Composition During First Year of Antiretroviral Therapy in People With HIV Compared With HIV-Uninfected Community Controls.. 35. 2022
Religious Leaders as Trusted Messengers in Combatting Hypertension in Rural Tanzanian Communities.. 34. 2021
Hypertensive Urgency in Tanzanian Adults: A 1-Year Prospective Study.. 33. 2020
Hypertension Contributes to Neuropathy in Patients With Type 1 Diabetes.. 32. 2019
Aortic Root Dilatation Is Associated With Incident Cardiovascular Events in a Population of Treated Hypertensive Patients: The Campania Salute Network.. 31. 2018
Target Organ Damage and Target Systolic Blood Pressure in Clinical Practice: The Campania Salute Network.. 31. 2018
Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.. 30. 2017
Atrial Dilatation Development in Hypertensive Treated Patients: The Campania-Salute Network.. 29. 2016
John H. Laragh MD: The Man.. 28. 2015
Pressor response to initial blood pressure monotherapy is associated with cardiovascular mortality.. 28. 2014
Assessing the associations of sodium intake with long-term all-cause and cardiovascular mortality in a hypertensive cohort.. 28. 2014
A tribute to John H. Laragh.. 27. 2014
John H. Laragh, MD: clinician-scientist.. 27. 2014
Tribute to John H. Laragh, MD.. 27. 2014
Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapy.. 27. 2014
Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension.. 27. 2014
Hemodynamic and echocardiographic profiles in African American compared with White offspring of hypertensive parents: the HyperGEN study.. 27. 2013
Prehypertension and incident acute coronary heart disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.. 27. 2013
Body mass index modulates blood pressure heritability: the Family Blood Pressure Program.. 27. 2013
Is pulse pressure an independent risk factor for incident acute coronary heart disease events? The REGARDS study.. 27. 2013
Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study.. 26. 2013
Diuretic use in black patients with uncontrolled hypertension.. 26. 2012
The AJH visits FDA.. 25. 2012
Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1.. 25. 2012
Regression of ECG-LVH is associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension; The LIFE study.. 25. 2012
Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE study.. 25. 2012
Dietary sodium intake and cardiovascular mortality: controversy resolved?. 25. 2012
Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease.. 25. 2012
Arterial stiffness is associated with carotid atherosclerosis in hypertensive patients (the Campania Salute Network).. 25. 2012
Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.. 25. 2012
Race differences in the physical and psychological impact of hypertension labeling.. 25. 2012
Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system.. 25. 2011
Enduring direct association of baseline plasma renin activity with all-cause and cardiovascular mortality in hypertensive patients.. 24. 2011
Predictors of blood pressure control among hypertensives in community health centers.. 24. 2011
Variants on chromosome 6p22.3 associated with blood pressure in the HyperGEN study: follow-up of FBPP quantitative trait loci.. 24. 2011
African-American ethnicity and cardiovascular risk factors are related to aortic pulse-wave velocity progression.. 24. 2011
The AJH visits NIH.. 24. 2011
Human dopamine β-hydroxylase promoter variant alters transcription in chromaffin cells, enzyme secretion, and blood pressure.. 24. 2010
Pressor responses to antihypertensive drug types.. 23. 2010
Heritability and genetic linkage of left ventricular mass, systolic and diastolic function in hypertensive African Americans (From the GENOA Study).. 23. 2010
Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study.. 23. 2010
Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.. 23. 2010
Estimation of 24-h sodium excretion from a spot urine sample using chloride and creatinine dipsticks.. 23. 2010
Racial disparities in hypertension control, but not treatment intensification.. 23. 2009
Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial.. 22. 2009
The association of cell cycle checkpoint 2 variants and kidney function: findings of the Family Blood Pressure Program and the Atherosclerosis Risk In Communities study.. 22. 2009
Evaluation of systolic properties in hypertensive patients with different degrees of diastolic dysfunction and normal ejection fraction.. 22. 2009
A practice-based trial of motivational interviewing and adherence in hypertensive African Americans.. 21. 2008
Independent association of coronary flow reserve with left ventricular relaxation and filling pressure in arterial hypertension.. 21. 2008
Change in pulse pressure/stroke index in response to sustained blood pressure reduction and its impact on left ventricular mass and geometry changes: the life study.. 21. 2008
Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study.. 21. 2008
Genome-wide linkage analysis of pulse pressure in American Indians: the Strong Heart Study.. 21. 2008
Hypertension control at physicians' offices in the United States.. 21. 2008
Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study.. 20. 2007
Effects of angiotensin receptor blockers on ambulatory plasma Renin activity in healthy, normal subjects during unrestricted sodium intake.. 20. 2007
Electrocardiographic and echocardiographic detection of myocardial infarction in patients with left-ventricular hypertrophy. The LIFE Study.. 20. 2007
Impaired inotropic response in type 2 diabetes mellitus: a strain rate imaging study.. 20. 2007
A whole genome scan for pulse pressure/stroke volume ratio in African Americans: the HyperGEN study.. 20. 2007
Coronary flow reserve in hypertensive patients with hypercholesterolemia and without coronary heart disease.. 20. 2007
Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients.. 19. 2006
Association of pulse pressure with cardiovascular outcome is independent of left ventricular hypertrophy and systolic dysfunction: the Strong Heart Study.. 19. 2006
Albumin-to-creatinine ratio predicts change in ambulatory blood pressure in normotensive persons: a 7.5-year prospective study.. 19. 2006
Determinants of sustained uncontrolled blood pressure in a national cohort of persons with diabetes.. 19. 2006
Left atrial systolic force and cardiovascular outcome. The Strong Heart Study.. 18. 2005
Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudy.. 18. 2005
Different normalizations for body size and population attributable risk of left ventricular hypertrophy: the MAVI study.. 18. 2005
Left atrial systolic force and cardiac markers of preclinical disease in hypertensive patients: the Hypertension Genetic Epidemiology Network (HyperGEN) Study.. 18. 2005
Exercise and cardiovascular outcomes by hypertensive status: NHANES I epidemiological follow-up study, 1971-1992.. 18. 2005
A genome scan for linkage with aortic root diameter in hypertensive African Americans and whites in the Hypertension Genetic Epidemiology Network (HyperGEN) study.. 18. 2005
Further evidence of a quantitative trait locus on chromosome 18 influencing postural change in systolic blood pressure: the Hypertension Genetic Epidemiology Network (HyperGEN) Study.. 18. 2005
Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study.. 18. 2005
Beyond hypertension toward guidelines for cardiovascular risk reduction.. 17. 2004
Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study.. 17. 2004
Genome scan for hypertension in nonobese African Americans: the National Heart, Lung, and Blood Institute Family Blood Pressure Program.. 17. 2004
Genome-wide linkage analyses for age at diagnosis of hypertension and early-onset hypertension in the HyperGEN study.. 17. 2004
Cyclic strain stimulates L-proline transport in vascular smooth muscle cells.. 17. 2004
Linkage of serum creatinine and glomerular filtration rate to chromosome 2 in Utah pedigrees.. 17. 2004
Pulse pressure is more susceptible to the white coat effect than is systolic blood pressure: observations from real-life ambulatory blood pressure monitoring.. 17. 2004
Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.. 17. 2004
Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats.. 17. 2004
Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients.. 17. 2004
The Arg16Gly polymorphism of the beta2-adrenergic receptor and left ventricular systolic function.. 16. 2003
Left ventricular mass regression in the LIFE study: effect of previous antihypertensive treatment.. 16. 2003
A genome-wide affected sibpair linkage analysis of hypertension: the HyperGEN network.. 16. 2003
Left ventricular mass change during treatment and outcome in patients with essential hypertension.. 15. 2002
Relation of insulin to left ventricular geometry and function in African American and white hypertensive adults: the HyperGEN study.. 15. 2002
Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.. 15. 2002
PAI-1 in human hypertension: relation to hypertensive groups.. 15. 2002
Linkage of left ventricular early diastolic peak filling velocity to chromosome 5 in hypertensive African Americans: the HyperGEN echocardiography study.. 15. 2002
Echocardiographic comparison of left ventricular structure and function in hypertensive patients with primary aldosteronism and essential hypertension.. 15. 2002
Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial.. 15. 2002
Sibling correlation of left ventricular mass and geometry in hypertensive African Americans and whites: the HyperGEN study. Hypertension Genetic Epidemiology Network.. 14. 2001
Ostial renal artery stent placement in patients 75 years of age or older.. 14. 2001
Endothelial dysfunction in resistance arteries is related to high blood pressure and circulating low density lipoproteins in previously treated hypertension.. 14. 2001
Hypertension treatment patterns in American Indians: the strong heart study.. 14. 2001
Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.. 14. 2001
Similar effects of isolated systolic and combined hypertension on left ventricular geometry and function: the LIFE Study.. 14. 2001
Dipping is superior to cusums analysis in assessment of the risk of stroke in a case-control study.. 14. 2001
Low-dose alpha/beta blockade in the treatment of essential hypertension.. 14. 2001
Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension.. 14. 2001
The association of blunted nocturnal blood pressure dip and stroke in a multiethnic population.. 13. 2000
Hormone replacement therapy and 24-hour blood pressure profile of postmenopausal women.. 13. 2000
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.. 13. 2000
Plasma renin activity in the emergency department and its independent association with acute myocardial infarction.. 13. 2000
Insulin and hypertension in the NHLBI Family Heart Study: a sibpair approach to a controversial issue.. 13. 2000
The relationship of serum androgens and ovulatory status to blood pressure in reproductive-age women.. 12. 1999
Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.. 12. 1999
Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene.. 12. 1999
Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement.. 12. 1999
Assessment of a new dipstick test in screening for microalbuminuria in patients with hypertension.. 11. 1998
Resting diastolic function and left ventricular mass are related to exercise capacity in hypertensive men but not in women.. 11. 1998
Epidemiology of risk in hypertensives: experience in treated patients.. 11. 1998
Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension.. 11. 1998
Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy.. 11. 1998
Alterations in membrane fatty acid unsaturation and chain length in hypertension as observed by 1H NMR spectroscopy.. 11. 1998
Serum ionized magnesium: relation to blood pressure and racial factors.. 10. 1997
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.. 10. 1997
Ambulatory blood pressure monitoring for detecting the relation between angiotensinogen gene polymorphism and hypertension.. 10. 1997
Relations of Doppler stroke volume and its components to left ventricular stroke volume in normotensive and hypertensive American Indians: the Strong Heart Study.. 10. 1997
Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients.. 10. 1997
Antihypertensive Drug Therapy. The effect of JNC criteria on prescribing patterns and patient status through the first year.. 9. 1996
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.. 9. 1996
Reduction of development of left ventricular hypertrophy in salt-loaded Dahl salt-sensitive rats by angiotensin II receptor inhibition.. 9. 1996
Cortisol metabolism in hypertensive patients who do and do not develop hypokalemia from diuretics.. 8. 1995
Echocardiographic assessment of left ventricular hypertrophy in rats using a simplified approach.. 7. 1994
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.. 6. 1993
A review of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report, 1993.. 6. 1993
Comparison of left ventricular mass and geometry in black and white patients with essential hypertension.. 6. 1993
The influence of dietary salt and plasma renin activity on myosin heavy chain gene expression in rat hearts.. 6. 1993
What is normal blood pressure? Comparison of ambulatory pressure level and variability in patients with normal or abnormal left ventricular geometry.. 6. 1993
Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure.. 6. 1993
Environmental determinants of urinary kallikrein excretion.. 6. 1993
Ambulatory blood pressure monitoring in offspring of hypertensive patients. Relation to left ventricular structure and function.. 6. 1993
Relation of left ventricular hypertrophy, afterload, and contractility to left ventricular performance in Goldblatt hypertension.. 5. 1992
Hemodynamic responses to verapamil monotherapy in patients with renal disease.. 4. 1991
Isolated T-wave abnormalities and evaluation of left ventricular wall motion after nifedipine for severe hypertension.. 4. 1991
DuP 753 increases survival in spontaneously hypertensive stroke-prone rats fed a high sodium diet.. 4. 1991
DuP 753 is a potent nonpeptide antagonist of angiotensin II receptors in isolated perfused rat kidney and cultured renal cells.. 4. 1991
Different plasma ionized calcium correlations with blood pressure in high and low renin normotensive adults in Utah.. 4. 1991
Sustained calcium channel blockade in the treatment of severe hypertension. A two year experience.. 3. 1990
A validation study of the instromedix Baro-Graf QD home blood pressure monitor.. 3. 1990
Echocardiographic measurement of left ventricular mass and volume in normotensive and hypertensive rats. Necropsy validation.. 3. 1990
Hypertension and peripheral insulin resistance. Possible mediating role of intracellular free magnesium.. 3. 1990
Clonidine-displacing substance is present in peripheral tissues of the rat.. 2. 1989
Hemodynamic responses to converting enzyme inhibition in patients with renal disease.. 2. 1989
Cardiac and hemodynamic adjustments to rapid and sustained blood pressure reduction.. 2. 1989
Effects of nicardipine on left ventricular hemodynamic patterns in systemic hypertension.. 2. 1989
A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex, and age differences.. 1. 1988
Using plasma renin (PRA) testing to design follow-up drug treatment strategies in hypertensive patients already taking antirenin system drugs. 2009
Is echocardiography essential in the management of newly diagnosed hypertension? 2006
Response to "Hazard of Low Salt Intake". 2015
Response to "salt intake and mortality". 2014
Response to "Article on sodium intake should include ethnic disclaimer". 2014
Population advice on salt restriction: the social issues. 2000
More on reliability of self-measured blood pressure. 1999
Active and passive component of ventricular diastole: is it possible to consider their interaction avoiding confusion? 1996
Sodium intake and salt sensitive hypertension. 1992
Summary of the International Workshop of Dietary Sodium and Human Health in China and the United States. 2009
International roundtable discussion of national guidelines for the detection, evaluation, and treatment of hypertension. 1993
N-of-1 Trials for Pediatric Hypertension? A Promising Approach to Increasing the Precision of Antihypertensive Treatment.. 36. 2023
Farewell and Hail: A Message From the Editor-in-Chief.. 28. 2015
Health insurance, or particularly its lack, and healthcare consequences among hypertensive Americans.. 27. 2014
JNC 8: shortcomings in process and treatment recommendations.. 27. 2014
The IOM report fails to detect evidence to support dietary sodium guidelines.. 26. 2013
The state of the journal: a report to AJH readers, reviewers, and authors.. 24. 2011
Editor's Note. The Renin-Angiotensin System: Today and Tomorrow in Research and Clinical Practice.. 24. 2011
The Cochrane review of sodium and health.. 24. 2011
AJH, globalization, and the Chinese Journal of Hypertension.. 22. 2009
Hypertension in sub-Saharan Africa: what physicians can do!. 22. 2009
AJH goes to China.. 21. 2008
Resistant hypertension: a clinical syndrome in search of a definition.. 21. 2008
Blood-pressure-related disease is a global health priority.. 21. 2008
Randomized clinical trials: prescriptions to be applied with caution!. 21. 2008
Regression of LVH or reduction of left ventricular mass?. 21. 2008
Plasma renin activity for predicting antihypertensive drug efficacy.. 21. 2008
Hypertension control: improved, but not enough!. 20. 2007
Regression of left ventricular hypertrophy: lodestar to stroke prevention in the treatment of hypertension?. 19. 2006
Plagiarism and scientific misconduct.. 17. 2004
JNC-7 versus renin-based strategies for optimal antihypertensive drug treatment. Another look at the evidence.. 17. 2004
Diagnosis of renal artery stenosis: combining gadolinimum-enhanced three-dimensional magnetic resonance angiography with functional magnetic resonance pulse sequences.. 16. 2003
ALLHAT and beyond.. 16. 2003
Barriers to blood pressure control.. 12. 1999
The great salt war.. 10. 1997
Hypertension and how to treat it: studies good and bad and a strategic suggestion.. 9. 1996
More news about calcium antagonists.. 9. 1996
Angiotensin converting enzyme inhibition of renin system activity induces reversal of hypertensive target organ changes. Do these effects predict a reduction in long-term morbidity?. 5. 1992
Hypertension Induced Morphological and Physiological Changes in Cells of the Arterial Wall. 2018
Dietary Sodium: Where Science and Policy Diverge. 2014
Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis. 2014
Renin-angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma renin levels. 2013
The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure. 2011
Five blood pressure loci identified by an updated genome-wide linkage scan: meta-analysis of the Family Blood Pressure Program. 2010
Aliskiren fails to lower blood pressure in patients who have either low PRA levels or whose PRA falls insufficiently or reactively rises. 2008
New onset diabetes during antihypertensive therapy. 2008
A summary of the effects of antihypertensive medications on measured blood pressure. 2005
Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. 2003
Neurogenic essential hypertension revisited: the case for increased clinical and research attention. 2003
A meta-analysis of genome-wide linkage scans for hypertension: the National Heart, Lung and Blood Institute Family Blood Pressure Program. 2003
Hypertension guidelines: criteria that might make them more clinically useful. 2002
Renin system activation and delayed function of the renal transplant. 2001
Management of hypertensive crises: the scientific basis for treatment decisions. 2001
Association between the alpha-adducin gene and hypertension in the HyperGEN Study. 2000
Left ventricular mass as a measure of preclinical hypertensive disease. 1992
Left ventricular mass as a predictor of development of hypertension. 1991
Calcium channel blockers and the prevention of atherosclerosis. 1990
Moderate sodium restriction. Do the benefits justify the hazards? 1990
Importance of left ventricular mass as a predictor of cardiovascular morbidity in hypertension. 1989
Echocardiographic insights into the pathophysiology and prognostic significance of hypertensive cardiac hypertrophy. 1989

VIVO Weill Cornell Medical College

American journal of hypertension Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)